CPH Post

Business

Novo Nordisk sued over anti-competitive practices

Drug distribution companies are suing for lost earnings after Novo Nordisk kept a cheaper generic version of its drug off the market


Novo Nordisk is trying to get the case thrown out of court (Photo: News Orseund)

January 17, 2014
09:44

by PS


Pharmaceutical giant Novo Nordisk is being sued in the US by drug distribution companies that accuse Novo of anti-competitive practices, Jyllands-Posten newspaper reports.

Novo Nordisk is accused of keeping cheaper generic copies of its drug Prandin off the market, forcing drug distribution companies to pay for a more expensive product.

Sales of Prandin earn the Danish company around 1.4 billion kroner a year, but their monopoly ended in June when a court found that its competitor Caraco was entitled to sell a generic copy.

READ MORE: Novo struggling with illegal hormone sales

Protecting monopoly
Caraco applied to produce its generic version in 2005 in advance of Novo Nordisk’s patent expiring in 2009, but Novo Nordisk blocked it through legal action and by attempting to extend its patent by changing its description in the so-called ‘Orange Book’ of approved drugs in the US.

The June ruling means that consumers have been paying inflated prices for the drug, leading three distribution companies – American Sales Company, Rochester Drug Co-op and Cardinal – to sue for lost earnings.

The generic version of Prandin is now on the market, and the damages will be calculated based on the price of the drug if the generic version had entered the market when it should have.

READ MORE: Lundbeck fined 700mn kroner for blocking generic

Blocking competition
Jyllands-Posten reports that the parties tend to settle in these types of cases and the damages could reach several hundred million kroner, but Novo Nordisk has said it will try and get the case dismissed from court.

Novo Nordisk is not the only Danish pharmaceutical accused of anti-competitive practices.

In June the EU fined Lundbeck 700 million kroner for conspiring with competitors to delay the introduction of generic versions of its drugs into the market. 



Related stories



Latest Comments

Being registered in Switzerland gives MSC more than a few advantages over...

(Calvin Bernhardt on April 24, 2014 01:44)

MD&T should give some serious thought to diversifying their product line,...

(Calvin Bernhardt on April 24, 2014 01:41)

As an Australian girl ,who married a Dane, reading this in Melbourne after...

(Grace Nugent on April 24, 2014 00:59)

You are UNFIT to keep animals! Your zoo is nothing but a slaughterhouse!!...

(Tracy Cole on April 24, 2014 00:35)

Great... More destructive immigrants. ; )

(Alex DeGre?t on April 23, 2014 23:49)

The picture is also misleading because it depicts rape as if it most often...

(Gena Grant on April 23, 2014 22:37)

Chinese people want to see where the Danes keep their horses and goats. Its...

(Calvin Bernhardt on April 23, 2014 21:42)

Well done

(Preeti Bhan Prasher on April 23, 2014 20:33)

What about foreigners who are already here under the Greencard scheme? I...

(Hildegard Andrea Wagner on April 23, 2014 20:16)

(November 30, -1 00:00)